STAAR Surgical Company (NASDAQ: STAA), the global leader in phakic IOLs with the EVO family of Implantable Collamer® Lenses ...

Please provide your email address to receive an email when new articles are posted on . According to Dhaliwal, the EVO ICL has five openings that allow the aqueous to flow through the ICL and “bathe ...

STAAR Surgical Company (NASDAQ: STAA), the global leader in phakic IOLs with the EVO family of Implantable Collamer® Lenses (EVO ICL™) for vision correction, today announced that the U.S. Food and ...

Please provide your email address to receive an email when new articles are posted on . A 36-year-old Hispanic man presented to the refractive surgery clinic at the New England Eye Center for surgical ...

Agreement is Largest Commitment to EVO ICL™ in the U.S. LAKE FOREST, Calif.--(BUSINESS WIRE)--STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of the EVO family of ...

Life is a lot clearer today. Thanks to technologies like light ray-tracing, EVO ICL implantable lenses and Refractive Lens Exchange, patients have a richer variety of choices when trying to attain ...

Despite facing headwinds in China, STAAR Surgical Company was able to boast growing revenues in Q4 2022. It enjoyed growing revenues in all of its key geographic markets. It enjoyed growing revenues ...